KRBPQ (Kiromic BioPharma) OCF Margin %: 0.00% (As of Dec. 2024)


What is Kiromic BioPharma OCF Margin %?

Kiromic BioPharma KRBPQ OCF Margin % is 0.00% as of Dec. 2024.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Kiromic BioPharma's Cash Flow from Operations for the three months ended in Dec. 2024 was $-3.65 Mil. Kiromic BioPharma's Revenue for the three months ended in Dec. 2024 was $0.00 Mil. Therefore, Kiromic BioPharma's OCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

As of today, Kiromic BioPharma's current OCF Yield % is -978,300.00%.

The historical rank and industry rank for Kiromic BioPharma's OCF Margin % or its related term are showing as below:


KRBPQ's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Kiromic BioPharma OCF Margin % Related Terms

Kiromic BioPharma OCF Margin % Historical Data

* Premium members only.

The historical data trend for Kiromic BioPharma's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kiromic BioPharma OCF Margin % Chart

Kiromic BioPharma Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Kiromic BioPharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kiromic BioPharma OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Kiromic BioPharma's OCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-19.458/0
= %

Kiromic BioPharma's OCF Margin for the quarter that ended in Dec. 2024 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=-3.648/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Kiromic BioPharma (KRBPQ) has a OCF Margin % of 0.00% as of Dec. 2024. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Kiromic BioPharma and its competitors.
Is Kiromic BioPharma's OCF Margin % too high?
Kiromic BioPharma's current OCF Margin % is 0.00%.
How does Kiromic BioPharma's OCF Margin % compare to VRTX and REGN?
Kiromic BioPharma's OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Kiromic BioPharma and its competitors. Kiromic BioPharma's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kiromic BioPharma stock overvalued right now?
Kiromic BioPharma (KRBPQ) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Kiromic BioPharma (KRBPQ), the current OCF Margin % is 0.00% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kiromic BioPharma Business Description

Address 7707 Fannin Street, Suite 200, Houston, TX, USA, 77054
Kiromic BioPharma Inc is a biotechnology company. It is an artificial intelligence (AI) driven, end-to-end allogeneic cell therapy company, currently developing the multi-indication allogeneic T cell therapy that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The company is a gene-editing which utilizes artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology.